Highlights from EAS 93rd Congress 2025

Key highlights from the EAS Congress 2025 focusing on new EAS consensus statement on chronic kidney metabolism, sex and gender differences in cardiovascular disease, Vesalius CV trial, PURSUIT trial, and pre/event management of LDL-C.

In the first part of the webinar, Prof. Lale Tokgozoglu summarizes the key highlights from the EAS Congress 2025 focusing on new EAS consensus statement on chronic kidney metabolism, sex and gender differences in cardiovascular disease, Vesalius CV trial, PURSUIT trial, and pre/event management of LDL-C.

In the second part of the webinar, Prof. Stephen Nicholls summarizes the key highlights focusing on recent clinical trial data on LDL-C lowering agents.

In the third part of the webinar, Prof. Khalid Fayez Alhabib, Prof. Lale Tokgozoglu, and Prof. Stephen Nicholls address audience questions in an interactive Q&A session following the key highlights from the EAS Congress 2025.